Tag Archives: black box warning

Draft study finds ‘no rationale’ for prescribing Avandia

A draft study on the effects of diabetes medication Avandia (rosiglitazone) has concluded that given the increased risk of stroke and heart disease and the alternative medication pioglitizone, there is no rationale for continuing to prescribe Avandia.

Read More »

Justice Dept. joins Risperdal whistleblower suits

The U.S. Attorney’s office in Boston announced that the Justice Department has filed a False Claims Act complaint against Johnson & Johnson and two subsidiaries for allegedly paying millions of dollars in kickbacks to nursing homes to prescribe its anti-psychotic ...

Read More »